Digital health innovator surpasses 250,000 prescriptions dispensed and achieves strongest month since launch
MedPal AI plc (LSE:MPAL) (FRA: Z1N), has delivered another major milestone in its growth journey, reporting record pharmacy dispensing volumes and reinforcing the strength of its technology-driven healthcare platform.
The company announced that more than 42,250 prescription items were dispensed during May 2026, making it the most successful month in the history of its pharmacy operations. The achievement surpasses the previous record of 41,000 items and demonstrates continued growth in patient demand across both NHS and private prescription services.
Equally significant is the company’s latest cumulative milestone. Since launching its pharmacy operations, MedPal AI has now dispensed over 250,000 prescription items, underlining the increasing adoption of its integrated digital health ecosystem and automated pharmacy platform.
Technology-Led Growth Driving Strong Financial Performance
The latest operational update highlights the scalability of MedPal AI’s business model. As dispensing volumes have increased, the company has successfully improved operational efficiency and profitability. Interim results for the six months ended February 2026 showed pharmacy gross margins exceeding 34%, reflecting the benefits of automation and operational leverage within the business.
Based on May’s performance, MedPal AI’s pharmacy division is now operating at an annualised turnover run rate of more than £5 million, providing a clear indication of the commercial traction being achieved.
Significant Capacity for Further Expansion
Chief Executive Officer and Founder Jason Drummond described the latest results as a strong validation of the company’s strategy.
The record month and quarter-million prescription milestone demonstrate how rapidly MedPal AI has scaled from a standing start. Importantly, management believes substantial capacity remains available within its dispensing infrastructure, providing a strong foundation for future growth without the need for significant additional investment.
Building the Future of Integrated Healthcare
MedPal AI is positioning itself at the intersection of artificial intelligence, digital wellness, clinical services and pharmacy fulfilment. Through its MedPal Health OS platform, users can integrate health data from more than 100 wearable devices and health applications, receiving personalised wellness insights while accessing clinical and pharmacy services through a single ecosystem.
The company’s wholly owned pharmacy subsidiary operates a 24/7 automated distribution centre powered by advanced robotic dispensing technology and AI-driven workflows. This combination enables efficient nationwide prescription fulfilment with same-day and next-day delivery capabilities.
Further strengthening its market opportunity, MedPal AI recently secured a partnership with Epassi UK, providing access to a potential audience of more than 11 million employees across major organisations.
Outlook
With record dispensing volumes, improving margins, growing revenues and substantial remaining operational capacity, MedPal AI appears well positioned to continue expanding its presence within the UK’s rapidly evolving digital healthcare market.
The latest results suggest that the company’s strategy of combining AI-powered healthcare services with automated pharmacy operations is gaining meaningful traction, creating a scalable platform capable of supporting long-term growth and value creation.
For more information visit https://www.medpal.ai/
Leave a Reply